Gilead rubbishes claim that antiviral drug, Remdesivir, failed to help Coronavirus patients in Chinese trial
Doctors suggest antiviral drugs would be most effective when administered as early as possible as it helps keep the virus from replicating in the blood.
Coronavirus Outbreak: Leaked results of a clinical trial hints Gliead's Remdesivir could be possible COVID-19 cure
During the trial, 113 patients were treated with the drug, most were discharged from the hospital in under a week, and only two died.
Fund raising activity goes 'cold' in India; PE, VC investments may dip up to 60% in 2020 due to COVID-19: EY
In the past few years, fund raising activity has been touching record highs, and grew 28 percent to $48 billion in 2019.
CRISPR works as molecular scissors that can trim away unwanted pieces of genetic material.
Sinogene which offers pet cloning carried out the process with the help of a surrogate mother beagle.
The technique still has one big hurdle to cross before heading towards clinical trials.
Biotech company may have unlocked the secret to reduce nicotine levels in cigarettes and tobacco plants
Investors are betting on a little-known biotech company to supply Big Tobacco with low-nicotine cigarettes.
Biotech major Biocon Ltd on Thursday reported Rs 147 crore consolidated net profit for second quarter (July-September) of fiscal 2016-17, registering 57 per cent annual growth from Rs 97 crore in same period year ago.
Nasscom's statements assume significance as the three major IT services companies of the country - Wipro, Infosys and TCS - have come out with a not-so-impressive earnings, giving rise to concerns about the jobs creation potential of the sector
Cloud-based tools and services are giving small designers and architecture firms the ability to collaborate with global teams and take on large-scale projects.
Billed as one of the first novel vaccines to be developed completely in the developing world, it is expected to help in significant reduction in infant deaths due to Rotavirus diarrhoea in India and other parts of the world.
Biotechnology is too complex and important to be left to the politicians alone. It is time an independent authority looked into the research, safety, release, and labeling of biotech products.